Butcher Arthur C 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Boston Scientific EVP Arthur Butcher Buys 6,851 Shares
What Happened
Arthur C. Butcher, EVP & Group President, MedSurg & APAC at Boston Scientific (BSX), acquired 6,851 shares on Feb 19, 2026 at $75.76 per share for a total of $519,032. The filing reports this as an acquisition (purchase) resulting from a discretionary transaction.
Key Details
- Transaction date and price: 2026-02-19, 6,851 shares at $75.76 each (total ~$519,032).
- Transaction type/code: Acquisition via discretionary transaction (code I) under the company plan.
- Method: Purchase made pursuant to an election to rebalance holdings in the company 401(k) Retirement Savings Plan (see footnote F1).
- Shares owned after transaction: Not specified in the Form 4; footnote F2 says the balance reflects the most current 401(k) plan data.
- Filing timeliness: Form filed 2026-02-27 for a 2026-02-19 trade — more than two business days after the transaction, so the filing appears late relative to the usual 2-business-day Form 4 deadline.
Context
This was a plan-based rebalancing purchase within the company 401(k) plan rather than an open-market buy. Such retirement-plan rebalancings are common and reflect plan elections rather than a discretionary open-market investment decision, though they still increase insider ownership.
Insider Transaction Report
Form 4
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
Transactions
- Discretionary Transaction
Common Stock
[F1][F2]2026-02-19$75.76/sh+6,851$519,032→ 20,205 total(indirect: By 401(k))
Holdings
- 55,792
Common Stock
Footnotes (2)
- [F1]Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
- [F2]Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
Signature
/s/ Susan Thompson, Attorney-in-Fact|2026-02-27